Group One Trading Portfolio holdings
AUM
$3.05B
1-Year Return
3.54%
This Quarter Return
+0.68%
1 Year Return
+3.54%
3 Year Return
+10.97%
5 Year Return
+15.65%
10 Year Return
+24.6%
AUM
$2.96B
AUM Growth
-$102M
(-3.3%)
Cap. Flow
-$84.7M
Cap. Flow
% of AUM
-2.86%
Top 10 Holdings %
Top 10 Hldgs %
22.57%
Holding
3,695
New
516
Increased
485
Reduced
755
Closed
616
Top Buys
| 1 |
Cigna
CI
|
+$165M |
| 2 |
Microsoft
MSFT
|
+$62.9M |
| 3 |
Meta Platforms (Facebook)
META
|
+$57.2M |
| 4 |
Boeing
BA
|
+$39.7M |
| 5 |
ARK Innovation ETF
ARKK
|
+$25.7M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$88.6M |
| 2 |
Tesla
TSLA
|
+$83.2M |
| 3 |
Apple
AAPL
|
+$78.8M |
| 4 |
Advanced Micro Devices
AMD
|
+$46.7M |
| 5 |
Biogen
BIIB
|
+$28.9M |
Sector Composition
| 1 | Technology | 19.96% |
| 2 | Healthcare | 19.19% |
| 3 | Consumer Discretionary | 12.21% |
| 4 | Energy | 9.38% |
| 5 | Financials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1426
BioAtla
BCAB
$45.5M
| $11.1K | ﹤0.01% |
+1,345
| New | +$11.1K |
|
1427
Spirit AeroSystems
SPR
$4.54B
| $11.1K | ﹤0.01% |
+374
| New | +$11.1K |
|
|
CNCE
1428
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $11K | ﹤0.01% |
1,891
-579
| -23% | -$3.38K |
|
1429
FTC Solar
FTCI
$106M
| $11K | ﹤0.01% |
411
+392
| +2,063% | +$10.5K |
|
1430
Heron Therapeutics
HRTX
$193M
| $11K | ﹤0.01% |
4,397
+2,236
| +103% | +$5.59K |
|
1431
PTC Therapeutics
PTCT
$4.85B
| $10.9K | ﹤0.01% |
286
+113
| +65% | +$4.31K |
|
1432
FingerMotion
FNGR
$95.6M
| $10.9K | ﹤0.01% |
+3,873
| New | +$10.9K |
|
1433
The ONE Group
STKS
$81.1M
| $10.8K | ﹤0.01% |
+1,710
| New | +$10.8K |
|
1434
Byrna Technologies
BYRN
$453M
| $10.5K | ﹤0.01% |
+1,345
| New | +$10.5K |
|
1435
Medifast
MED
$154M
| $10.5K | ﹤0.01% |
91
+39
| +75% | +$4.5K |
|
|
MRIN
1436
DELISTED
Marin Software
MRIN
| $10.4K | ﹤0.01% |
+1,738
| New | +$10.4K |
|
|
GATO
1437
DELISTED
Gatos Silver, Inc.
GATO
| $10.4K | ﹤0.01% |
2,549
-17,812
| -87% | -$72.8K |
|
|
SRAX
1438
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
| $10.4K | ﹤0.01% |
+6,789
| New | +$10.4K |
|
1439
Owens & Minor
OMI
$412M
| $10.4K | ﹤0.01% |
+531
| New | +$10.4K |
|
1440
scPharmaceuticals
SCPH
$302M
| $10.4K | ﹤0.01% |
1,444
-25,616
| -95% | -$184K |
|
1441
Verrica Pharmaceuticals
VRCA
$44.9M
| $10.2K | ﹤0.01% |
372
-88
| -19% | -$2.42K |
|
|
GTY
1442
Getty Realty Corp
GTY
$1.6B
| $10.2K | ﹤0.01% |
301
-199
| -40% | -$6.74K |
|
1443
Jaguar Health
JAGX
$4.26M
| $10.2K | ﹤0.01% |
1
| – | – |
|
|
SRGA
1444
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $10.1K | ﹤0.01% |
5,167
-394
| -7% | -$772 |
|
|
MRNS
1445
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $10K | ﹤0.01% |
2,519
-9,393
| -79% | -$37.4K |
|
|
RGLS
1446
DELISTED
Regulus Therapeutics
RGLS
| $10K | ﹤0.01% |
7,315
-81
| -1% | -$111 |
|
1447
Braskem
BAK
$1.33B
| $9.96K | ﹤0.01% |
1,083
| – | – |
|
1448
Spero Therapeutics
SPRO
$107M
| $9.93K | ﹤0.01% |
5,741
-49,359
| -90% | -$85.4K |
|
|
PGTI
1449
DELISTED
PGT, Inc.
PGTI
| $9.9K | ﹤0.01% |
+551
| New | +$9.9K |
|
|
ORAN
1450
DELISTED
Orange
ORAN
| $9.88K | ﹤0.01% |
+1,000
| New | +$9.88K |
|